Maria C. Scaini
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
A high-penetrance intergenic variant at 9p21 confers melanoma susceptibility.
Journal: Research square
Published: May 25, 2026
A high-penetrance intergenic variant at 9p21 confers melanoma susceptibility.
Journal: Research square
Published: May 25, 2026
High BRAF variant allele frequency predicts poor outcomes in metastatic melanoma patients treated with BRAF/MEK inhibitors.
Journal: Journal of translational medicine
Published: October 02, 2025
Dissecting the Spectrum of Rare BRAF Mutations in Melanoma: A Nation-Wide Study by the Italian Melanoma Intergroup (IMI).
Journal: Pigment cell & melanoma research
Published: August 07, 2025
A model workflow for microfluidic enrichment and genetic analysis of circulating melanoma cells.
Journal: Scientific reports
Published: November 07, 2024
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.
Journal: Transplantation and cellular therapy
Published: December 31, 2023
Molecular Modeling Unveils the Effective Interaction of B-RAF Inhibitors with Rare B-RAF Insertion Variants.
Journal: International journal of molecular sciences
Published: July 06, 2023
Investigating the Retained Inhibitory Effect of Cobimetinib against p.P124L Mutated MEK1: A Combined Liquid Biopsy and in Silico Approach.
Journal: Cancers
Published: June 29, 2022
Putative Clinical Potential of ERBB2 Amplification Assessment by ddPCR in FFPE-DNA and cfDNA of Gastroesophageal Adenocarcinoma Patients.
Journal: Cancers
Published: March 10, 2022
Last Updated: 09/26/2026